Lecture 21 - Pharmacology Of Opioids Flashcards
1
Q
Opioids - morhine like drugs
A
- endogenous substances: endorphins, enkephalines
- morphine, oxygocone, methadone, codeine, buprenorphine
- all work through GPCR
2
Q
Prescribing opiates: considerations
A
- tolerance: increased doce/concentration required for a given effect with chronic administration. This works through progressive internalisation of GPCR receptors
- withdrawal: physical : tachycardia, treamor, sweats
- dependence: psychological: craving, drug seeking behavior
3
Q
Action of opiates
A
- Analgesia for acute and chronic pain, not very effective for neuropathic pain
- euphoria: sense of contentment, well being
- sedation
- respiratory depression: decreased sensitivity to raised PaCO2
- dyspnoea; very effective
4
Q
Aciton of opioates continued
A
- GI tract: increase sphincter tone: treat diarrhoea. Can cause constipation as a side effect
- Pupillary constriction because of receptors in oculomotor nucleus
5
Q
Morphine kinetics
A
- bioavilibility 20-30%
- T1/2 short: 2-3 hours
- sustained release form
6
Q
Morphine metabolism
A
Conjugated in phase II with glucuronic acid
- M6G and M3G
- M6G has twixe the potenxy of morphine when given systematically but less effective at crossing blood brain barrier
- M3G is possibly responsible for adverse CNS effect such as dysphoris
7
Q
Excretion of morphine metabolites
A
- M6G and M3G are excreted renally
- dose reduction required if impaired renal function
- magnitude of contributin of M6G to analgesia not established in ptients when morphine is given
8
Q
Morphine route of administration
A
- oral
- subcutaneous: repeated injections/ infusions/ osmotic mini-pump
- intrathecal or epidural: tendency for rostral spread in CSF, may affect C4/5 roots
9
Q
Codeine
A
- 3-methyl morphine
- higher oral bioavailablility
- inactive until converted to morphine
- less potent than morphine
- less euphoria
- constipation
- cough suppression
Converted to morphone with CYP2D6 (only 8% of it) - caucasians have a higher proportion of poor metabolisers
10
Q
Oxycodone
A
- not a prodrug
- binds directly to opiate recpetors
- good oral bioavailability (80%, comapred to 30% for morphine)
- nearly full agonist
- use orally
- short acting: endone (4-5 houris)
- sustained release preparation: Oxycontine -> 12 hours duration
11
Q
Oxycodone: how to release constipation
A
- oral administration + naloxone
- oxycodone is absorbed and has the systemic analgesic effects
- oxycodone in bowel causes constipation
- naloxone prevents abuse
- systemic effects of naloxone unlikely
12
Q
Fentanyl
A
- synthetic opioid
- mainly u agonist
- 60-80% more potent than morphoine
- high lipid solubility
- rapid transit of blood brain barrier
- short half life: used in anesthesia
- patient controlled analgesia
- transdermal patches
13
Q
Buprenorphine
A
- strong analgesis for short term use
- less effect han morhine on respiratory depression and CNS Depression
- partial agonist
- long half life
- available as injection or sublingual
- long half life
14
Q
Suboxone
A
- buprenorphine + naloxone
- sublingual film or tablet
- used for treating opiate dependence
- buprenorphine dissociates slowly from u receptors in CNS
- if taken IV (illegal): naloxone blocks opiate receptors, causes unpleasant symptoms of opiate withdrawal: deters IV use
- naloxone very low bioavailability if taken sublingual
15
Q
Tramadol
A
- analgesia due to u agonist and inhibition of neuronal noradrenaline and serotonin uptake
- side effects: less constipation, less respiratory depression less addiction potential
- less analgesia